Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis C after liver transplantation.

P A Sheiner1

  • 1Department of Surgery, Mount Sinai School of Medicine, New York, New York, USA. patricia.sheiner@mountsinai.org

Seminars in Liver Disease
|August 18, 2000
PubMed
Summary

Hepatitis C recurrence post-liver transplant is common, with treatments like OKT3 increasing incidence and severity. High viral loads and genotype 1b may worsen outcomes, while treatment options remain limited.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pulsatile Hematuria From Procurement Core Needle Biopsy: A Case Report.

Transplantation proceedings·2018
Same author

Academic careers and lifestyle characteristics of 171 transplant surgeons in the ASTS.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2011
Same author

Preservation of recipient middle hepatic vein for drainage of anterior sector veins in adult-to-adult living-donor liver transplantation.

Transplantation proceedings·2009
Same author

Open abdomen management with human acellular dermal matrix in liver transplant recipients.

Transplantation proceedings·2008
Same author

Leukemia after liver transplant.

Transplantation·2001
Same author

Critical graft size in adult-to-adult living donor liver transplantation: impact of the recipient's disease.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2001

Area of Science:

  • Hepatology
  • Transplant Immunology
  • Virology

Background:

  • Hepatitis C is a leading cause of end-stage liver disease and liver transplantation.
  • Recurrence of Hepatitis C post-transplant affects up to 75% of patients, with severe outcomes in 7%.

Purpose of the Study:

  • To review factors influencing Hepatitis C recurrence after liver transplantation.
  • To assess the impact of immunosuppression, viral load, and genotype on recurrence.
  • To evaluate current and potential treatment strategies for recurrent Hepatitis C.

Main Methods:

  • Literature review of studies on Hepatitis C recurrence post-liver transplant.
  • Analysis of factors including immunosuppressive agents, viral kinetics, and HCV genotypes.
  • Evaluation of treatment efficacy for recurrent Hepatitis C and outcomes of retransplantation.

Main Results:

  • Immunosuppressive treatments like OKT3 are associated with increased incidence and severity of Hepatitis C recurrence.
  • High pre- or post-transplant viral loads and Hepatitis C genotype 1b are linked to poorer prognosis and faster progression.
  • Current treatment options for recurrent Hepatitis C are limited, with combination therapy showing short-term benefits but unknown long-term outcomes.

Conclusions:

  • Recurrent Hepatitis C post-liver transplant is influenced by immunosuppression, viral factors, and genotype.
  • Effective prophylactic and therapeutic strategies for recurrent Hepatitis C are needed.
  • Retransplantation for recurrent Hepatitis C is challenging due to high perioperative mortality, predicted by renal failure or sepsis.

Related Experiment Videos